Quality

  1. Home
  2. Products
  3. Customized ADCs
  4. LYPD3
  5. Anti-LYPD3 (clone B01-3)-lysine-toxophore ADC

Anti-LYPD3 (clone B01-3)-lysine-toxophore ADC (ADC-W-111)

This ADC product is comprised of an anti-LYPD3 monoclonal antibody (clone B01-3) conjugated via a lysine linker to toxophore.
  • Antibody clone #
  • B01-3

 ADC Target

  • Name
  • LYPD3
  • Alternative Names
  • LYPD3; LY6/PLAUR Domain Containing 3;GPI-Anchored Metastasis-Associated Protein C4.4A Homolog;Matrigel-Induced Gene C4 Protein;MIG-C4;GPI-Anchored Metastasis-Associated Protein Homolog;Ly6/PLAUR Domain-Containing Protein 3;2310061G07Rik;
  • Target Entrez Gene ID
  • 27076
  • Overview
  • This gene is a Protein Coding gene. GO annotations related to this gene include laminin binding. An important paralog of this gene is LYPD5.

 ADC Antibody

  • Overview
  • Anti-LYPD3 antibody, clone # B01-3
  • Clone #
  • B01-3
  • Species Reactivity
  • Human

 ADC Linker

  • Name
  • lysine
  • Description
  • Noncleavable linkers, is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.

 ADC payload drug

  • Name
  • toxophore loading

For Research Use Only. NOT FOR CLINICAL USE.

Related Products

Online Inquiry
Name:
*Phone:
*E-mail Address:
*Products or Services Interested:
Company/Institution
Project Description:









Customized FluoroAb™

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.

Contact us
USA
 
 Tel:
 Fax:
 Email:
Europe
 
 Tel:
 Email:
Germany
 
 Tel:
 Email:


Inquiry

Top